SCHEMBL4690423

SCHEMBL4690423

CCC(=O)N1C[C@@H](NC(=O)c2ccc(N3CCCCC3=O)cc2)[C@H](NC(=O)c2ccc(Cl)s2)C1

nearest known ligand 0.75

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
F10 P00742 20/20 0.75
F2 P00734 4/20 0.75
F11 P03951 3/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4690422 1.00 F10 (0.75) F10F2F11
SCHEMBL5631572 0.91 F10 (0.70) F10F2F11
SCHEMBL5434026 0.91 F10 (0.70) F10F2F11
SCHEMBL5432864 0.91 F10 (0.71) F10F2F11
SCHEMBL5432609 0.90 F10 (0.79) F10F2F11
SCHEMBL5442385 0.89 F10 (0.75) F10F2F11
SCHEMBL5631313 0.89 F10 (0.74) F10F2F11
SCHEMBL5433022 0.89 F10 (0.74) F10F2F11
SCHEMBL5633444 0.89 F10 (0.74) F10F2F11
SCHEMBL5629967 0.86 F10 (0.76) F10F2F11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7205318-B2 Lactam-containing cyclic diamines and derivatives as a factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-04-17 US claimed
EP-1603572-A4 LACTAM-CONTAINING CYCLIC DIAMINES AND DERIVATIVES AS FACTOR XA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2008-06-25 EP disclosed
US-7205318-B2 Lactam-containing cyclic diamines and derivatives as a factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-04-17 US disclosed
EP-1603572-A1 LACTAM-CONTAINING CYCLIC DIAMINES AND DERIVATIVES AS FACTOR XA INHIBITORS Bristol-Myers Squibb Company (US) 2005-12-14 EP disclosed
WO-2004082687-A1 LACTAM-CONTAINING CYCLIC DIAMINES AND DERIVATIVES AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-09-30 WO disclosed